Loading viewer...
investor_presentation
Format: PDF investor_presentation
Trevena Inc. (NASDAQ: TRVN) presents its product pipeline strategy and clinical development initiatives as of August 2024. The presentation outlines the company's therapeutic candidates, commercial operations, and strategic alternatives for its marketed product OLINVYK, led by CEO Carrie L. Bourdow and the company's experienced leadership team.
investor_presentation
25 Pages
Zynex, Inc.
Münchener Rückversicherungs-Gesellschaft Investor Presentation — May 2020
investor_presentationinvestor_presentation
38 Pages
Münchener Rückversicherungs-Gesellschaft
Pacific Life Global Funding II Q1 2024 Investor Presentation
investor_presentationinvestor_presentation
32 Pages
Pacific Life Insurance Company